Scholarly Index
Takashi Sugita
Meiji Pharmaceutical University; 10,628 total citations; 420 total publications; best world rank #59
Meiji Pharmaceutical University
10,628Total citations
420Total publications
55H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Nail Diseases and Treatments | Lifetime | 59 | JP 1 | 99.25 |
| Plant Pathogens and Fungal Diseases | Lifetime | 254 | JP 2 | 99.14 |
| Yeasts and Rust Fungi Studies | Lifetime | 78 | JP 4 | 98.69 |
| Antifungal resistance and susceptibility | Lifetime | 251 | JP 2 | 98.56 |
| Fungal Infections and Studies | Lifetime | 202 | JP 1 | 98.58 |
| Dermatology and Skin Diseases | Lifetime | 300 | JP 16 | 98.44 |
| Plant Disease Resistance and Genetics | Lifetime | 538 | JP 26 | 97.28 |
| Infectious Diseases and Mycology | Lifetime | 326 | JP 9 | 95.81 |
| Bee Products Chemical Analysis | Lifetime | 888 | JP 21 | 93.16 |
| Dermatological diseases and infestations | Lifetime | 519 | JP 4 | 88.37 |
| Infections and bacterial resistance | Lifetime | 958 | JP 47 | 74.61 |
| Antifungal resistance and susceptibility | 2021-2025 | 516 | JP 14 | 90.45 |
| Nail Diseases and Treatments | 2021-2025 | 257 | JP 8 | 88.01 |
| Yeasts and Rust Fungi Studies | 2021-2025 | 252 | JP 6 | 80.45 |
| Fungal Infections and Studies | 2021-2025 | 828 | JP 19 | 82.18 |
| Infectious Diseases and Mycology | 2021-2025 | 317 | JP 24 | 76.22 |
| Signaling Pathways in Disease | 2021-2025 | 605 | JP 28 | 56.92 |